Skip to main content
. 2020 Jun 5;5(2):172–182. doi: 10.1089/can.2019.0051

Table 3.

Knowledge Regarding Qualified Conditions for Medical Cannabis Among Health Care Providers in Washington State, 2018 (N=310)

Condition Qualified condition Correctly identified
Incorrectly identified
Don't know/missing
n % n % n %
Cancer Yes 289 93.2 6 1.9 15 4.8
Intractable paina Yes 248 80.0 16 5.2 46 14.8
Nauseab Yes 239 77.1 22 7.1 49 15.8
Crohn's diseasec Yes 237 76.5 19 6.1 54 17.4
Glaucomad Yes 215 69.4 28 9.0 67 21.6
Hepatitis Ce Yes 201 64.8 35 11.3 74 23.9
Epilepsy or other seizure disorder Yes 195 62.9 40 12.9 75 24.2
Depression No 165 53.2 54 17.4 91 29.4
HIV Yes 156 50.3 55 17.7 99 31.9
Spasticity disorders Yes 154 49.7 45 14.5 111 35.8
Multiple sclerosis Yes 151 48.7 44 14.2 115 37.1
Anxiety No 130 41.9 106 34.2 74 23.9
Post-traumatic stress disorder Yes 118 38.1 78 25.2 114 36.8
Traumatic brain injury Yes 90 29.0 83 26.8 137 44.2
Lupus No 81 26.1 83 26.8 146 47.1
Tourette's syndrome No 78 25.2 79 25.5 153 49.4
Rheumatoid arthritis No 73 23.5 117 37.7 120 38.7
Neurofibromatosis No 66 21.3 102 32.9 142 45.8
Parkinson's disease No 64 20.6 128 41.3 118 38.1
a

Intractable pain unrelieved by standard medical treatments and medications.

b

Diseases, including anorexia, which result in nausea, vomiting, wasting, appetite loss, cramping, seizures, muscle spasms, or spasticity, when these symptoms are unrelieved by standard treatments or medications.

c

Crohn's disease with debilitating symptoms unrelieved by standard treatments or medications.

d

Glaucoma either acute or chronic, with increased intraocular pressure unrelieved by standard treatments and medications.

e

Hepatitis C with debilitating nausea or intractable pain unrelieved by standard treatments or medications.